ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Shouping Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.